Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: the STEP 4Life randomized clinical trial [with consumer summary]
Greysen SR, Oon AL, Harkins K, Rareshide C, Mondal A, Patel MS, Grill JD, Karlawish J
Alzheimer's & Dementia 2024 Aug;20(8):5450-5459
clinical trial
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

INTRODUCTION: Physical activity is associated with reduced risk of cognitive and functional decline but scalable, sustainable interventions for populations at risk for Alzheimer's disease (AD) and AD and related dementias (ADRD) are lacking. METHODS: A 12-week randomized-controlled trial was conducted with a 3-week follow-up using a national AD prevention registry (GeneMatch). The control group (n = 50) set step goals and received daily feedback. The intervention group (n = 44) also received a behaviorally designed game based on achieving step goals and reinforced by a support partner. RESULTS Intervention participants (94 participants, mean age 70, 78% female) had greater change in mean daily step count than control of 1699 steps/day (95% confidence interval (CI) 1149 to 2249), p < 0.0001, which was sustained in the follow-up period at 1219 steps/day (95% CI 455 to 1983), p = 0.0018. Carriers of the apolipoprotein E epsilon4 gene (high risk) did not perform differently than non-carriers; however, high self-reported risk perception was associated with higher activity. DISCUSSION: A gamified intervention was effective in promoting and sustaining higher physical activity in older adults at genetic risk for AD/ADRD. TRIAL REGISTRATION: ClinicalTrials.gov: NCT05069155.

Full text (sometimes free) may be available at these link(s):      help